logo
Federal court rejects challenge to Oklahoma law banning gender transition treatment for minors

Federal court rejects challenge to Oklahoma law banning gender transition treatment for minors

Fox News4 days ago
A federal appeals court upheld an Oklahoma law banning gender transition medical treatment for minors.
The law, Senate Bill 613, makes it a felony for health care workers to provide gender transition treatment such as puberty-blocking drugs and hormones to a minor.
The bill was passed by the state's Republican-controlled legislature and signed into law by GOP Gov. Kevin Stitt in 2023.
Five families of transgender children and a physician challenged the state's law, arguing it violated their constitutional rights.
The plaintiffs, represented by Lambda Legal, the American Civil Liberties Union (ACLU) and the ACLU of Oklahoma, argued that lawmakers approved the law with discriminatory intent, pointing to a 2022 law that froze pandemic relief funding for the hospital system OU Health unless Oklahoma Children's Hospital halted gender transition treatment for minors.
A federal judge declined to block the law from taking effect in 2023, writing that transgender medical care for children is "an area in which medical and policy debate is unfolding" and the state "can rationally take the side of caution before permitting irreversible medical treatments of its children."
The U.S. Supreme Court in June upheld a similar Tennessee ban on transgender-related treatment, a ruling relied upon when the 10th Circuit issued its ruling in Oklahoma on Wednesday, when a three-judge panel ruled unanimously that Oklahoma's law is constitutional.
The laws in Tennessee and Oklahoma "are functionally indistinguishable," Circuit Judge Joel M. Carson, an appointee of President Donald Trump, wrote in the order.
The order says Oklahoma's law does not violate the Constitution and was not intended to discriminate against transgender children.
"We recognize the importance of this issue to all involved," Carson wrote. "But this remains a novel issue with disagreement on how to assure children's health and welfare. We will not usurp the legislature's judgment when it engages in 'earnest and profound debate about the morality, legality, and practicality' of gender transition procedures for minors."
"While we respect that Plaintiffs disagree with the legislature's assessment of such procedures' risks, that alone does not invalidate a democratically enacted law on rational-basis grounds," the judge added.
Oklahoma's Republican Attorney General Gentner Drummond praised the court's ruling in a post on social media.
"For years, radical left activists pushed the lie of 'gender transition' procedures for minors. The truth is much simpler: there is no such thing," he wrote Thursday on X. "Today, here in Oklahoma, we celebrate a new decision from the 10th Circuit Court of Appeals that recognizes this truth and protects our children. I am proud to have fought this battle and won. This is a victory for our children, for our Constitution, and for common sense."
Attorneys for the plaintiffs, on the other hand, described Wednesday's ruling as "a devastating outcome for transgender youth and their families across Oklahoma and another tragic result of the Supreme Court's errant and harmful ruling" in the Tennessee case.
"Oklahoma's ban is openly discriminatory and provably harmful to the transgender youth of this state, putting political dogma above parents, their children, and their family doctors," the attorneys said in a joint statement. "While we and our clients consider our next steps, we want all transgender people and their families across Oklahoma to know we will never stop fighting for the future they deserve and their freedom to be themselves."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cardinal Health expands urology focus with $1.9bn Solaris Health deal
Cardinal Health expands urology focus with $1.9bn Solaris Health deal

Yahoo

time20 minutes ago

  • Yahoo

Cardinal Health expands urology focus with $1.9bn Solaris Health deal

US drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal aims to expand the Specialty Alliance, the distributor's multi-speciality management services organisation (MSO) platform, in which Cardinal will gain a stake of around 75%. The acquisition will also create the Urology Alliance, comprising a collaborative network of urology providers within Cardinal's Specialty Alliance MSO, as well as resonate with plans to expand the delivery of urological patient care. Cardinal's Solaris buyout complements its recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology, signalling its urologic strategy. The transaction is expected to be completed by the end of this year, pending customary closing conditions. Cardinal Health CEO Jason Hollar stated that growing the Speciality Alliance is a 'top priority' for the company, with the latest urology purchase leaving it 'well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of the Specialty Alliance, Specialty Networks and Cardinal Health'. Research indicates there is a shortage of urologists in the US, with 62% of US counties lacking a practising urologist and just one new urologist entering the field for every ten retiring. The figures lead to challenges in the broader field, including delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, with these particularly pronounced in rural communities. GlobalData's senior medical analyst Selena Yu foresees Cardinal's acquisition as reflecting a shift from drug distribution with a 'lower profit margin, towards higher margin speciality care in urology'. Yu said: 'MSOs help streamline backend work like billing and staffing to allow for physicians to focus on care. 'Additionally, with a large network of specialists, patients can receive care in the same region by different care specialists, which will reduce wait times and improve care continuity. Additionally, the Cardinal Health Alliance has other specialities like oncology specialists, which makes referrals more streamlined.' Cardinal's acquisition coincided with the release of its Q4 2025 financials. The company's profits per share came in at $2.08, beating the forecasted $2.03, yet profits for the quarter came in at $60.2bn, below the $60.92bn forecast, prompting a pre-market stock drop of more than 11% on 12 August. Cardinal's share price has since recovered to a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on 11 August. "Cardinal Health expands urology focus with $1.9bn Solaris Health deal" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Effettua l'accesso per consultare il tuo portafoglio

Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications

Yahoo

time20 minutes ago

  • Yahoo

Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications

WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound, used for weight loss and diabetes treatment. "Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme," Attorney General Paxton said. The lawsuit builds upon Attorney General's previous legal action to hold drug manufacturers accountable for fraud and abuse, the statement added. Last year, Paxton had sued insulin manufacturers, including Lilly and pharmacy benefit managers (PBMs), alleging that manufacturers artificially raised the prices of insulin and then paid a significant, undisclosed portion back to the PBMs for preferential treatment in return. Eli Lilly did not immediately respond to a Reuters request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Trump Selects EJ Antoni To Lead The Bureau Of Labor Statistics
Trump Selects EJ Antoni To Lead The Bureau Of Labor Statistics

Yahoo

time20 minutes ago

  • Yahoo

Trump Selects EJ Antoni To Lead The Bureau Of Labor Statistics

U.S. President Donald Trump tapped EJ Antoni, chief economist at the Heritage Foundation, to lead the Bureau of Labor Statistics, saying on Truth Social that he wants numbers that are honest and accurate. The job requires Senate confirmation. Warning! GuruFocus has detected 6 Warning Signs with INTC. The move comes after Trump fired BLS Commissioner Erika McEntarfer on August 1 following a weak July jobs report and downward revisions to the prior two months. Antoni has been outspoken about BLS methods and revisions, so expect tough questions on data independence, seasonal adjustments and how he would handle future revisions if confirmed. Economists across the spectrum quickly defended McEntarfer and the BLS, calling the agency a gold standard for apolitical statistics. Critics warn that politicizing labor data could erode investor trust, complicate Federal Reserve communication and inject more volatility into payrolls days if market participants start doubting the goalposts. credible labor data anchors rate expectations, equity risk premia and Treasury pricing. Even minor doubts can move nomination puts BLS governance in the spotlight. Watch the Senate process and the next jobs reports for any sign of methodological shifts. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store